Balancing benefits and risks in the era of biologics

Giovanni Adami,Kenneth G. Saag,Roland Chapurlat,Nuria Guañabens,Glenn Haugeberg,Willem F. Lems,Radmila Matijevic,Nicola Peel,Denis Poddubnyy,Piet Geusens

Balancing benefits and risks in the era of biologics

2019

Giovanni Adami
Kenneth G. Saag
Roland Chapurlat
Nuria Guañabens
Glenn Haugeberg
Willem F. Lems
Radmila Matijevic
Nicola Peel
Denis Poddubnyy
Piet Geusens

Biologics are substances synthetized from biological sources used in the prevention and treatment of several diseases. Rheumatologists have many years of experience with biologics for the treatment...

Keywords:

Romosozumab
Physical therapy
Medicine
Alternative medicine
Denosumab
Rheumatoid arthritis
Osteoporosis
Infliximab
Certolizumab pegol
Intensive care medicine
Randomized controlled trial
Adverse effect

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations